⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EDSA News
Edesa Biotech, Inc. Common Shares
Form 8-K
sec.gov
EDSA
Form 8-K
sec.gov
EDSA
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study
globenewswire.com
EDSA
Form 8-K
sec.gov
EDSA
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
globenewswire.com
EDSA
Edesa Biotech Announces Proposed Public Offering
globenewswire.com
EDSA
Form 8-K
sec.gov
EDSA
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
globenewswire.com
EDSA
Parent Project Muscular Dystrophy Hosts 2026 Annual Conference in Orlando, Florida
prnewswire.com
CAPR
SRPT
CATX
BMRA
EDSA
ENTX
SLDB
WVE
Form 8-K
sec.gov
EDSA